Department of Justice 2005 – Federal Register Recent Federal Regulation Documents

DEA is amending its regulations to require additional recordkeeping and reporting requirements for drug products containing gamma-hydroxybutyric acid (GHB) for which an application has been approved under the Federal Food, Drug, and Cosmetic Act. DEA makes these changes under section 4 of the ``Hillory J. Farias and Samantha Reid Date-Rape Drug Prohibition Act of 2000.'' These additional requirements are necessary to protect against the diversion of GHB for illicit purposes.

This notice establishes initial 2005 aggregate production quotas for controlled substances in Schedules I and II of the Controlled Substances Act (CSA).